Novel 2‑Aryloxazoline Compounds Exhibit an Inhibitory Effect on Candida spp., Including Antifungal-Resistant Isolates

Because of the increased resistance to currently available antifungals, fungal infections represent a significant challenge to human health. Herein, we report the synthesis of 2-aryloxazoline derivatives from the reaction between l-threonine and derivatives of salicylic or naphthoic acid. In total,...

Full description

Saved in:
Bibliographic Details
Published in:ACS medicinal chemistry letters 2020-12, Vol.11 (12), p.2470-2475
Main Authors: Argomedo, Luis M. Z, Barroso, Vinicius M, Barreiro, Cristiane S, Darbem, Mariana P, Ishida, Kelly, Stefani, Hélio A
Format: Article
Language:English
Subjects:
Letter
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Because of the increased resistance to currently available antifungals, fungal infections represent a significant challenge to human health. Herein, we report the synthesis of 2-aryloxazoline derivatives from the reaction between l-threonine and derivatives of salicylic or naphthoic acid. In total, 26 compounds were obtained and tested against species of Candida, Cryptococcus, and Aspergillus. We found that all of the compounds inhibited the growth of Candida species at low concentrations (
ISSN:1948-5875
1948-5875
DOI:10.1021/acsmedchemlett.0c00449